37.83
Schlusskurs vom Vortag:
$37.84
Offen:
$38.11
24-Stunden-Volumen:
884.62K
Relative Volume:
0.57
Marktkapitalisierung:
$8.64B
Einnahmen:
$5.30B
Nettoeinkommen (Verlust:
$-624.00M
KGV:
-12.33
EPS:
-3.0692
Netto-Cashflow:
$42.00M
1W Leistung:
-2.07%
1M Leistung:
+4.16%
6M Leistung:
-8.40%
1J Leistung:
-32.71%
Lineage Inc Stock (LINE) Company Profile
Firmenname
Lineage Inc
Sektor
Branche
Telefon
(800) 678-7271
Adresse
46500 HUMBOLDT DRIVE, NOVI
Compare LINE vs PLD, PSA, EXR, EGP, CUBE
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
LINE
Lineage Inc
|
37.83 | 8.64B | 5.30B | -624.00M | 42.00M | -3.0692 |
|
PLD
Prologis Inc
|
138.97 | 126.68B | 8.79B | 3.57B | 4.27B | 3.5567 |
|
PSA
Public Storage
|
300.35 | 51.30B | 4.79B | 1.91B | 2.93B | 9.6238 |
|
EXR
Extra Space Storage Inc
|
146.36 | 30.64B | 3.34B | 997.83M | 1.73B | 4.4718 |
|
EGP
Eastgroup Properties Inc
|
190.92 | 9.99B | 679.77M | 236.60M | 385.49M | 4.6371 |
|
CUBE
Cubesmart
|
38.93 | 8.79B | 1.08B | 385.85M | 627.25M | 1.68 |
Lineage Inc Stock (LINE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-13 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-12-18 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-11-06 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-08-11 | Herabstufung | BofA Securities | Buy → Underperform |
| 2025-07-01 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-06-23 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2025-06-23 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-06-12 | Herabstufung | BNP Paribas Exane | Neutral → Underperform |
| 2025-05-06 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-04-10 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-28 | Eingeleitet | Citigroup | Neutral |
| 2025-01-14 | Eingeleitet | Exane BNP Paribas | Neutral |
| 2024-12-20 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-09-18 | Eingeleitet | CapitalOne | Overweight |
| 2024-09-16 | Eingeleitet | CapitalOne | Overweight |
| 2024-08-19 | Eingeleitet | Deutsche Bank | Hold |
| 2024-08-19 | Eingeleitet | Evercore ISI | In-line |
| 2024-08-19 | Eingeleitet | Goldman | Buy |
| 2024-08-19 | Eingeleitet | JP Morgan | Overweight |
| 2024-08-19 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-08-19 | Eingeleitet | Mizuho | Neutral |
| 2024-08-19 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-08-19 | Eingeleitet | Piper Sandler | Overweight |
| 2024-08-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-08-19 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-08-19 | Eingeleitet | Truist | Buy |
| 2024-08-19 | Eingeleitet | UBS | Neutral |
| 2024-08-19 | Eingeleitet | Wells Fargo | Equal Weight |
Alle ansehen
Lineage Inc Aktie (LINE) Neueste Nachrichten
Will Lineage Cell Therapeutics Inc. stock keep raising dividendsJuly 2025 Setups & Weekly High Potential Alerts - mfd.ru
Lineage Logistics Acquires Two California Cold Storage Facilities - Heavy Duty Trucking
Will Lineage Cell Therapeutics Inc. stock hit new highs in YEAR2025 Investor Takeaways & Real-Time Volume Spike Alerts - mfd.ru
Can Lineage Inc. deliver consistent EPS growth2025 Bull vs Bear & Safe Capital Growth Stock Tips - mfd.ru
Ballet Theatre Of Maryland And Full Circle Dance Company Come Together For “LINEAGE” - Severna Park Voice
Cold Chain Market to Reach US$ 919.9 Bn by 2032 as Key Players - openPR.com
IQ EQ FUND MANAGEMENT IRELAND Ltd Grows Stake in Lineage, Inc. $LINE - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lineage, Inc. (LINE) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Johnson Fistel, PLLP Begins Investigation on Behalf of - GlobeNewswire
Lineage stock rises as Barclays maintains rating despite data center deal - Investing.com UK
Lineage stock rises as Barclays maintains rating despite data center deal By Investing.com - Investing.com India
Portfolio Shifts: What are the analyst revisions for AFJKUIs Lineage Inc stock a good investment in YEARWeekly Gains Report & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
Lineage price target lowered to $45 from $51 at RBC Capital - MSN
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lineage, Inc. (LINE) And Encourages Investors to Connect - Stockhouse
Bronstein, Gewirtz & Grossman, LLC Encourages Lineage, Inc. (LINE) Investors to Inquire about Securities Investigation - accessnewswire.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lineage, Inc. (LINE) And Encourages Stockholders to Connect - ACCESS Newswire
Lineage Focused on Bringing Certainty to Global Movement of Food - Nareit
Strs Ohio Lowers Holdings in Lineage, Inc. $LINE - MarketBeat
Is Lineage Inc. benefiting from innovation trends2025 Earnings Impact & Free Community Consensus Stock Picks - mfd.ru
Lineage, Inc. Announces Tax Treatment for 2025 Distributions - Yahoo Finance
Hedge Fund Moves: Can Lineage Cell Therapeutics Inc maintain sales growth2025 Volatility Report & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Lineage subsidiary proposes euro-denominated notes offering - MSN
U.S. Cold Storage Market to Reach US$ 91.4 Bn by 2032 as Key Players - openPR.com
Trade Report: Is Lineage Cell Therapeutics Inc a top pick in the sectorRisk Management & Verified Entry Point Detection - baoquankhu1.vn
LINELINEAGE INC Latest Stock News & Market Updates - Stock Titan
Lineage, Inc. (NASDAQ:LINE) Given Average Recommendation of "Reduce" by Analysts - MarketBeat
Market Wrap: Can Lineage Inc deliver alphaDollar Strength & Expert Curated Trade Ideas - baoquankhu1.vn
Market Moves: Is Lineage Cell Therapeutics Inc trading at a discountShare Buyback & Long-Term Safe Investment Plans - baoquankhu1.vn
What are the future prospects of Lineage Cell Therapeutics IncJuly 2025 Snapshot & Fast Exit and Entry Trade Guides - baoquankhu1.vn
Guidance Update: Will Lineage Cell Therapeutics Inc stock hit new highs in YEARMarket Trend Review & Momentum Based Trading Signals - baoquankhu1.vn
Trade Recap: Will Lineage Cell Therapeutics Inc benefit from rising consumer demandTrade Exit Summary & Advanced Technical Signal Analysis - baoquankhu1.vn
Analysts Offer Insights on Real Estate Companies: Digital Realty (DLR) and Lineage, Inc. (LINE) - The Globe and Mail
What is Lineage Inc. s P E ratio telling usM&A Rumor & Safe Capital Growth Plans - mfd.ru
Lineage Therap Sells 12 Million Shares to Janus - MSN
Trading Recap: What are the analyst revisions for AFJKUIs Lineage Inc stock a good investment in YEARQuarterly Trade Review & Daily Oversold Bounce Ideas - baoquankhu1.vn
Aug Action: Can Lineage Inc be the next market leaderQuarterly Portfolio Summary & Daily Oversold Bounce Ideas - baoquankhu1.vn
Aug Levels: Is GFL Environmental Inc stock showing strong momentum2025 Trading Recap & AI Based Trade Execution Alerts - baoquankhu1.vn
Travel Stocks: Can Lineage Inc outperform under higher oil pricesJuly 2025 Review & Community Driven Trade Alerts - baoquankhu1.vn
Assessing Lineage (LINE) Valuation As Analyst Downgrades Reset Market Expectations - simplywall.st
Lineage to Report Fourth-Quarter and Full-Year 2025 Financial Results on February 25, 2026 - Business Wire
Market Overview: Should I average down on Lineage Cell Therapeutics Inc stockEarnings Trend Report & Accurate Technical Buy Alerts - baoquankhu1.vn
Lineage (NASDAQ:LINE) Lowered to "Strong Sell" Rating by Zacks Research - MarketBeat
The Bull Case For Lineage (LINE) Could Change Following Barclays Downgrade And Rising Analyst Caution - Sahm
Lineage Takes Delivery of Genetically Engineered iPSC Line with Hypoimmunity Edits from Factor Bioscience - BioInformant
Aug PostEarnings: Can Lineage Cell Therapeutics Inc stock outperform in 2025 bull market - moha.gov.vn
Lineage Shares Fall After Barclays Downgrade - marketscreener.com
Aug Sentiment: Will Lineage Inc stock deliver strong dividend growth2025 Valuation Update & Long Hold Capital Preservation Plans - moha.gov.vn
LINE: Barclays Downgrades Lineage, Lowers Price Target to $38.00 - GuruFocus
Lineage (NASDAQ:LINE) Given "Equal Weight" Rating at Barclays - MarketBeat
Barclays Downgrades Lineage to Equalweight From Overweight, Lowers Price Target to $38 From $47 - marketscreener.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lineage, Inc. (LINE) And Encourages Shareholders to Connect - ACCESS Newswire
Finanzdaten der Lineage Inc-Aktie (LINE)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):